GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » Price-to-Tangible-Book

Ascentage Pharma Group International (HKSE:06855) Price-to-Tangible-Book : 82.94 (As of May. 13, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Price-to-Tangible-Book?

As of today (2025-05-13), Ascentage Pharma Group International's share price is HK$45.95. Ascentage Pharma Group International's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was HK$0.55. Hence, Ascentage Pharma Group International's Price to Tangible Book Ratio of today is 82.94.

The historical rank and industry rank for Ascentage Pharma Group International's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06855' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.27   Med: 10.25   Max: 84.27
Current: 83.55

During the past 9 years, Ascentage Pharma Group International's highest Price to Tangible Book Ratio was 84.27. The lowest was 5.27. And the median was 10.25.

HKSE:06855's Price-to-Tangible-Book is ranked worse than
98.75% of 1199 companies
in the Biotechnology industry
Industry Median: 2.61 vs HKSE:06855: 83.55

A closely related ratio is called PB Ratio. As of today, Ascentage Pharma Group International's share price is HK$45.95. Ascentage Pharma Group International's Book Value per Sharefor the quarter that ended in Dec. 2024 was HK$0.90. Hence, Ascentage Pharma Group International's P/B Ratio of today is 51.34.


Ascentage Pharma Group International Price-to-Tangible-Book Historical Data

The historical data trend for Ascentage Pharma Group International's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International Price-to-Tangible-Book Chart

Ascentage Pharma Group International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only 10.25 5.27 20.36 - 82.22

Ascentage Pharma Group International Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.36 11.52 - 11.28 82.22

Competitive Comparison of Ascentage Pharma Group International's Price-to-Tangible-Book

For the Biotechnology subindustry, Ascentage Pharma Group International's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascentage Pharma Group International's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's Price-to-Tangible-Book falls into.


;
;

Ascentage Pharma Group International Price-to-Tangible-Book Calculation

Ascentage Pharma Group International's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=45.95/0.554
=82.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Ascentage Pharma Group International Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascentage Pharma Group International Business Description

Traded in Other Exchanges
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Takeda Pharmaceuticals International Ag 2101 Beneficial owner
Takeda Pharmaceuticals Company Limited 2201 Interest of corporation controlled by you
Gao Sharon Xia
Zhai Yifan
Yang Dajun
Wang Shaomeng
Li Ju-yun
Healthquest Pharma Limited
Guo Edward Ming
Ascentage Limited
South Dakota Trust Company Llc 2301 Trustee
Tian Yuan 2201 Interest of corporation controlled by you
Zhao Li 2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you

Ascentage Pharma Group International Headlines

No Headlines